Search Results - "Weitzman, James I"

A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies by Al-Samkari, Hanny, Parnes, Aric D, Goodarzi, Katayoon, Weitzman, James I, Connors, Jean M, Kuter, David J

“…Chemotherapy-induced thrombocytopenia (CIT) frequently complicates cancer treatment causing chemotherapy delays, dose reductions, and discontinuation. There is…”
Get full text

A Clinical Prediction Model to Assess Risk for Chemotherapy-Related Hospitalization in Patients Initiating Palliative Chemotherapy by Brooks, Gabriel A, Kansagra, Ankit J, Rao, Sowmya R, Weitzman, James I, Linden, Erica A, Jacobson, Joseph O

“…Chemotherapy-related hospitalizations in patients with advanced cancer are common, distressing, and costly. Methods to identify patients at high risk of…”
Get more information

Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study by Haydu, J. Erika, Maron, Jenny S., Redd, Robert A., Gallagher, Kathleen M.E., Fischinger, Stephanie, Barnes, Jeffrey A., Hochberg, Ephraim P., Johnson, P. Connor, Takvorian, R.W., Katsis, Katelin, Portman, Daneal, Ruiters, Jade, Sechio, Sidney, Devlin, Mary, Regan, Connor, Blumenthal, Kimberly G., Banerji, Aleena, Judd, Allen D., Scorsune, Krista J., McGree, Brianne M., Sherburne, Maryanne M., Lynch, Julia M., Weitzman, James I., Lei, Matthew, Kotton, Camille N., Dighe, Anand S., Maus, Marcela V., Alter, Galit, Abramson, Jeremy S., Soumerai, Jacob D.

“…Chronic lymphocytic leukemia (CLL), the most common leukemia worldwide, is associated with increased COVID-19 mortality. Previous studies suggest only a…”
Get full text

A Multicenter Study of Romiplostim to Treat Chemotherapy-Induced Thrombocytopenia in Solid Tumors and Lymphoid Malignancies by Al-Samkari, Hanny, Parnes, Aric D, Goodarzi, Katayoon, Weitzman, James I, Connors, Jean M., Kuter, David J.

“…Introduction: Chemotherapy-induced thrombocytopenia (CIT) is a common complication in cancer patients causing chemotherapy treatment delays, dose reductions,…”
Get full text

A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumor s and hematologic malignancies by Al-Samkari, Hanny, Parnes, Aric D., Goodarzi, Katayoon, Weitzman, James I., Connors, Jean M., Kuter, David J.

“…Chemotherapy-induced thrombocytopenia (CIT) frequently complicates cancer treatment causing chemotherapy treatment delays, dose reductions, and…”
Get full text

Rates of Thrombotic Events in Hypereosinophilic Syndrome and the Effect of Molecular Aberrations in Thrombotic Risk by Leiva, Orly, Baker, Olesya, Brunner, Andrew M., Al-Samkari, Hanny, Leaf, Rebecca Karp, Rosovsky, Rachel P., Fathi, Amir T., Weitzman, James I, Bornikova, Larissa, Nardi, Valentina, Hobbs, Gabriela S.

“…Background: Idiopathic hypereosinophilia and hypereosinophilic syndrome (HES) comprise a rare, heterogeneous group of hematologic disorders characterized by…”
Get full text